This white paper details the clinical application of intestinal ultrasound (IUS) in the management of inflammatory bowel disease (IBD), specifically Crohn’s disease and ulcerative colitis. It outlines how IUS supports the treat-to-target strategy by providing objective, repeatable, and non-invasive assessments of bowel inflammation.
The paper covers IUS diagnostic parameters—bowel wall thickness (BWT), color Doppler signal, and echostratification—and explains how these are used in validated scoring systems such as IBUS-SAS, BUSS, and the Milan Ultrasound Criteria (MUC). Clinical case studies illustrate how IUS is used to assess disease activity and track treatment response in real time.
Samsung’s RS85 Prestige ultrasound system and associated probes are introduced as ideal platforms for high-resolution IUS, offering a customizable bowel report that auto-calculates indices and enables standardized monitoring. IUS is also shown to support transmural healing assessments and guide therapeutic decisions over the long term.
Future directions include the integration of shear wave elastography to evaluate bowel stiffness and artificial intelligence to automate image analysis. With its versatility and patient-friendly approach, IUS is positioned as a key tool for improving clinical outcomes in IBD management.
To learn more about how to perform intestinal ultrasound examinations in IBD, including standardized parameter measurements, refer to the white paper on intestinal ultrasound protocol for inflammatory bowel disease .
